Page results
-
UCLH is to trial a set of interventions to improve hospital care for people who use opioids such as heroin.
-
Young cancer patients and staff couldn’t believe their eyes when David Beckham paid a visit to the University College Hospital Macmillan Cancer Centre earlier this year.
-
Four stars of Arsenal’s women’s team surprised children and young people at UCLH last week, delivering gifts to patients and meeting families and staff.
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Tuesday 31 January 2023.
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
A large trial at UCLH is looking to optimise chemotherapy for young people with nodular lymphocyte predominant Hodgkin lymphoma (NLPHL).
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
-
UCLH chair Baroness Julia Neuberger has today announced that Professor Marcel Levi will be stepping down from his role as UCLH chief executive on 31 March 2021.
File results
-
FOI/2024/0620 - Women/ birthing people diverted to other NHS trusts in 2024
-
FOI/2024/0623 - Patient numbers sent to use MRI scanner at London Zoo from 2014-2024
-
FOI/2024/0628 - Service personnel/ armed force families access to speech and language therapy for children who stammer
-
FOI/2024/0633 - Adults, children diagnosed/ living with Glycogen storage disease type V (Mcardle's disease)
-
FOI/2024/0635 - Patient incidences/ injuries due to chiropractic treatment
-
FOI/2024/0648 - Performance management Policy for July 2020 to November 2022
-
FOI/2024/0651 - Family history units/ familial cancer services
-
FOI/2024/0652 - Overseas visitors invoiced in 2023/24
-
FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma
-
FOI/2024/0663 - Diagnosis discharge codes and cases 2018-19 to 2022-23